Edinburgh Instruments appoints new CEO

Edinburgh Instruments, Livingston, UK: Following the acquisition of Edinburgh Instruments Ltd by Techcomp Europe Ltd (25th February 2013), EI announces the appointment of Mark Vosloo as CEO . Mark joins EI from Oxford Instruments where he has held various general manager and senior commercial roles for the past nine years. Prior to this he has [...]

AB SCIEX Proteomics Scientist Wins HUPO 2013 Science and Technology Award

FRAMINGHAM, Mass - The Human Proteome Organization (HUPO) will award Christie Hunter, Ph.D, director of proteomics applications at AB SCIEX, its 2013 Science and Technology Award at an award ceremony during next week's HUPO 2013 conference in Japan. Dr. Hunter is being recognized for her contributions to the development and commercialization of a breakthrough approach [...]

Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2014 and Reaffirms Fiscal 2013 Guidance

CINCINNATI -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2014 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2014, management expects net sales to be in the range of $203 to $208 [...]

Kalen Biomedical, LLC Signs Distribution Agreement with Beijing LeBo Biological

Montgomery Village, MD - Kalen Biomedical, LLC (https://www.kalenbiomed.com) is pleased to announce a distribution agreement with LeBo Biological in Beijing. Kalen Biomedical, LLC is pleased to offer premium lipoprotein products to Chinese researchers through Beijing LeBo Biological. "LeBo Biological contributes professional support along with premium products for their customers," said Kathy K. Foxx, President of [...]

Agreement with GMI Inc to Increase Servicing and Support Capacity in North America

Arrayjet Ltd is pleased to announce the signing of a servicing agreement with GMI Inc (Ramsey, Minnesota), to provide local servicing and support to its North America customer base. The market for microarrayers continues to grow and North America remains a key territory for Arrayjet. With a growing install base it was critical moving forward [...]

Trovagene collaborates with USC in clinical study evaluating cancer monitoring technology

SAN DIEGO, Sept. -- Trovagene, Inc. (NASDAQ: TROV), a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays. The study is designed to demonstrate that [...]

Seahorse XF Technology Helps P&G Research the Science of Skin

Billerica, MA – As reported in this week’s The Scientist Magazine, Seahorse Bioscience XF Extracellular Flux technology is being utilized by Procter & Gamble (P&G) skin care scientists to pioneer applications in cellular bioenergetics, to discover the right ingredient combinations that could positively impact skin’s natural bioenergy production and re-energize aged skin cells. P&G scientists [...]

Agreement with GMI Inc to Increase Servicing and Support Capacity in North America

Arrayjet Ltd is pleased to announce the signing of a servicing agreement with GMI Inc (Ramsey, Minnesota), to provide local servicing and support to its North America customer base. The market for microarrayers continues to grow and North America remains a key territory for Arrayjet. With a growing install base it was critical moving forward [...]

Enzymatics Acquires ArcherDx and Next-Generation Diagnostic Technology

Beverly, MA and Boulder, CO -- Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment. The deal consists of cash, equity and potential milestones worth up to $50 million. Jason Myers, [...]

MicroAqua: a 12 party consortium drives the development of a microarray for a rapid, inexpensive and efficient testing for waterborne pathogens

Dortmund and Berlin, Germany -- µAQUA is the acronym for the EU research project “Universal microarrays for the evaluation of fresh-water quality based on detection of pathogens and their toxins” which has been funded by the 7th Framework Programme of the European Commission since 2011. Its overall goal is to develop efficient, sensitive, robust, rapid [...]

Access IBO on Knowledge Center